Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone vs dexamethasone for COPD exacerbation
IRCT20200818048447N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone and dexamethasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Yasouj University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20200818048447N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200818048447N1.